Table 4.
Sensitivity and Specificity of single antibodies for predicting fusion status in rhabdomyosarcoma
| Antibody | Sensitivity | Specificity |
|---|---|---|
| ARMS/ERMS TMA | ||
| AP2beta | 93% | 94% |
| HMGA2 | 89% | 73% |
| Myogenin | 100% | 51% |
| NOS1 | 83% | 94% |
| Lookback TMA | ||
| AP2beta | 91% | 93% |
| HMGA2 | 83% | 80% |
| Myogenin | 96% | 65% |
| NOS1 | 71% | 96% |